Literature DB >> 15142483

Virologic Diagnosis, Viral Monitoring, and Treatment of Epstein-Barr Virus Infectious Mononucleosis.

Hal B. Jenson1.   

Abstract

Epstein-Barr virus (EBV) is the cause of infectious mononucleosis and is associated with severe infections in immunocompromised patients. EBV is also causally linked with several human malignancies. The heterophile antibody test and EBV-specific antibody tests remain the principal means of diagnosis of initial infection in otherwise healthy patients. Enzyme-linked immunosorbent assays have replaced the traditional immunofluorescence assays for EBV-specific antibodies. Several newer molecular diagnostic tests have become available that facilitate accurate monitoring of infection. The role of these tests for patients with uncomplicated infectious mononucleosis is limited, although these tests are being increasingly used to monitor the state and level of EBV replication for severe infections and among immunocompromised patients. Antiviral therapy has a limited, short-term effect on oropharyngeal shedding but has proven ineffective for the clinical manifestations of infectious mononucleosis. Patients with selected complications frequently benefit from short-term corticosteroid therapy.

Entities:  

Year:  2004        PMID: 15142483     DOI: 10.1007/s11908-004-0009-2

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  47 in total

1.  Regression of oral hairy leukoplakia after orally administered acyclovir therapy.

Authors:  L Resnick; J S Herbst; D V Ablashi; S Atherton; B Frank; L Rosen; S N Horwitz
Journal:  JAMA       Date:  1988-01-15       Impact factor: 56.272

Review 2.  Oral hairy leukoplakia: observations in 95 cases and review of the literature.

Authors:  P A Reichart; A Langford; H R Gelderblom; H D Pohle; J Becker; H Wolf
Journal:  J Oral Pathol Med       Date:  1989-08       Impact factor: 4.253

3.  Acyclovir for treatment of infectious mononucleosis: a meta-analysis.

Authors:  D Torre; R Tambini
Journal:  Scand J Infect Dis       Date:  1999

4.  Comparison of EBV neutralization tests based on abortive infection or transformation of lymphoid cells and their relation to membrane reactive antibodies (anti-MA).

Authors:  A de Schryver; G Klein; J Hewetson; G Rocchi; W Henle; G Henle; D J Moss; J H Pope
Journal:  Int J Cancer       Date:  1974-03-15       Impact factor: 7.396

5.  Neurologic complications of infectious mononucleosis after steroid therapy.

Authors:  R T Waldo
Journal:  South Med J       Date:  1981-09       Impact factor: 0.954

6.  Evaluation of 12 commercial tests for detection of Epstein-Barr virus-specific and heterophile antibodies.

Authors:  A L Bruu; R Hjetland; E Holter; L Mortensen; O Natås; W Petterson; A G Skar; T Skarpaas; T Tjade; B Asjø
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

7.  Epstein-Barr viral load assessment in immunocompetent patients with fulminant infectious mononucleosis.

Authors:  Jan A M van Laar; Corinne M P Buysse; Ann C T M Vossen; Björn Hjálmarsson; Bart van Den Berg; Kirsten van Lom; Jaap Deinum
Journal:  Arch Intern Med       Date:  2002-04-08

Review 8.  Quantitative analysis of Epstein-Barr virus DNA in plasma and serum: applications to tumor detection and monitoring.

Authors:  Y M Lo
Journal:  Ann N Y Acad Sci       Date:  2001-09       Impact factor: 5.691

9.  Haemolytic anaemia complicating Epstein-Barr virus infection.

Authors:  F Whitelaw; M G Brook; N Kennedy; W R Weir
Journal:  Br J Clin Pract       Date:  1995 Jul-Aug

10.  Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay.

Authors:  H Kimura; M Morita; Y Yabuta; K Kuzushima; K Kato; S Kojima; T Matsuyama; T Morishima
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

View more
  5 in total

Review 1.  Serological diagnosis of Epstein-Barr virus infection: Problems and solutions.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2012-02-12

2.  Evidence for the role of B cells and immunoglobulins in the pathogenesis of multiple sclerosis.

Authors:  Bharath Wootla; Aleksandar Denic; B Mark Keegan; Jeffrey L Winters; David Astapenko; Arthur E Warrington; Allan J Bieber; Moses Rodriguez
Journal:  Neurol Res Int       Date:  2011-09-22

3.  Is multiple sclerosis an autoimmune disease?

Authors:  Bharath Wootla; Makoto Eriguchi; Moses Rodriguez
Journal:  Autoimmune Dis       Date:  2012-05-16

4.  Fulminant Epstein-Barr virus - infectious mononucleosis in an adult with liver failure, splenic rupture, and spontaneous esophageal bleeding with ensuing esophageal necrosis: a case report.

Authors:  Daniel Busch; Sarah Hilswicht; Dominik S Schöb; Klaus T von Trotha; Karsten Junge; Nikolaus Gassler; Son Truong; Ulf P Neumann; Marcel Binnebösel
Journal:  J Med Case Rep       Date:  2014-02-05

5.  Acute cholestatic hepatitis induced by Epstein-Barr virus infection in an adult: a case report.

Authors:  Anthony Khoo
Journal:  J Med Case Rep       Date:  2016-03-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.